Company news

Cumberland Pharmaceuticals Inc. news in 2024

Cumberland Pharmaceuticals Inc.'s news releases, calls and decks from 2024, newest first.

View company

FDA approves Acetadote® sNDA

December 8, 2024

Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update

November 6, 2024

Cumberland Pharmaceuticals receives FDA Orphan Drug and rare pediatric disease designations for new treatment of Duchenne muscular dystrophy

November 5, 2024

Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024

August 5, 2024

Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update

May 6, 2024

Cumberland Pharmaceuticals to announce first quarter 2024 financial results

April 29, 2024

Cumberland Pharmaceuticals Reports Annual 2023 Financial Results

March 4, 2024

Calls in 2024